Skip to content

Clinical trials

Terminated Phase 1/2 Multiple Sclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 1/2 Status: Terminated Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20083
20101
20121
20151
20171
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
US Department of Veterans Affairs2
Atara Biotherapeutics1
Cambridge University Hospitals NHS Foundation Trust1
Center for Medicinal Cannabis Research1
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla1
National Institute of Neurological Disorders and Stroke (NINDS)1
Northwestern University1
Oregon Health and Science University1
Teva GTC1
University Hospital, Toulouse1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis12
Muscle Spasticity3
Autoimmune Diseases2
Fatigue2
Marijuana Abuse2
Multiple Sclerosis, Chronic Progressive2
Autoimmune Diseases of the Nervous System1
Demyelinating Diseases1
Epstein-Barr Virus Infections1
Inflammation1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.